AstraZeneca AB
PolandAll drugs from this manufacturer
-
The medicinal product is used for the maintenance treatment of airway obstruction symptoms in patients with asthma (in combination with inhaled glucocorticosteroids) and to prevent exercise-induced symptoms. It is also indicated for the treatment of airway obstruction symptoms in individuals with chronic obstructive pulmonary disease (COPD).
Dosage form: powder for inhalation
Active substance Dosage formoterol fumarate 20 mg ATC: R03AC13
-
The medicinal product is used for the maintenance treatment of airway obstruction symptoms in patients with asthma (in combination with inhaled steroids) and for the prevention of exercise-induced symptoms. It is also indicated for the treatment of airway obstruction symptoms in patients with chronic obstructive pulmonary disease (COPD).
Dosage form: powder for inhalation
Active substance Dosage formoterol fumarate 10 mg ATC: R03AC13
-
The medicine is used to control inflammation in bronchial asthma, in the treatment of croup syndrome (acute laryngitis, tracheitis, and bronchitis), and in exacerbations of chronic obstructive pulmonary disease (COPD).
Dosage form: suspension for nebulization
Active substance Dosage budesonide 0.5 mg ATC: R03BA02
-
The medicine is used in the treatment of bronchial asthma and chronic obstructive pulmonary disease (COPD).
Dosage form: powder for inhalation
Active substance Dosage budesonide 100 mcg ATC: R03BA02
-
The medicine is used in the treatment of bronchial asthma and chronic obstructive pulmonary disease (COPD).
Dosage form: powder for inhalation
Active substance Dosage budesonide 200 mcg ATC: R03BA02
-
The medicine is used to treat asthma in adults, adolescents, and children aged 6 years and older. It helps prevent asthma symptoms by reducing inflammation in the lungs and relaxing the muscles in the airways, which makes breathing easier.
Dosage form: powder for inhalation
Active substance Dosage budesonide 80 mcg formoterol fumarate 4.5 mcg ATC: R03AK07
-
The medicine is used for the treatment of asthma in adults and adolescents (from 12 to 17 years old) and for the treatment of symptoms of chronic obstructive pulmonary disease (COPD) in adults.
Dosage form: powder for inhalation
Active substance Dosage budesonide 160 mcg formoterol fumarate 4.5 mcg ATC: R03AK07
-
This medicine is used to treat asthma in adults and adolescents aged 12 to 17 years, as well as to treat the symptoms of chronic obstructive pulmonary disease (COPD) in adults.
Dosage form: powder for inhalation
Active substance Dosage budesonide 320 mcg formoterol fumarate 9 mcg ATC: R03AK07
-
In men, it is used for the treatment of prostate cancer. In women, the medicine is intended for the treatment of breast cancer, endometriosis, benign uterine growths (fibroids), reduction of the thickness of the uterine lining before surgery, and in the treatment of infertility.
Dosage form: implant, subcutaneous
Active substance Dosage goserelin acetate 3.6 mg ATC: L02AE03
-
The medicine is used to treat prostate cancer that responds to hormonal therapy.
Dosage form: implant, subcutaneous
Active substance Dosage goserelin acetate 10.8 mg ATC: L02AE03